Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
North Carolina Voter Guide 2024: Who's running, how, where, when to vote in NC election
Recommended
Help North Carolina rebuild: WRAL's Hurricane Helene recovery fund raises $900K+
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Seismic Therapeutic, Inc.
Seismic Therapeutic Presents New Preclinical Data on S-1117 in Autoantibody-Mediated Diseases Including Myasthenia Gravis at MGFA Scientific Session at AANEM Annual Meeting
October 15, 2024
From
Seismic Therapeutic, Inc.
Via
Business Wire
Seismic Therapeutic Announces Participation at Upcoming October Scientific and Medical Conferences
September 30, 2024
From
Seismic Therapeutic, Inc.
Via
Business Wire
Seismic Therapeutic Appoints Julie Eastland as Independent Board Director
September 23, 2024
From
Seismic Therapeutic, Inc.
Via
Business Wire
Seismic Therapeutic to Participate in Upcoming Investor Conferences
August 26, 2024
From
Seismic Therapeutic, Inc.
Via
Business Wire
Seismic Therapeutic Appoints Brendan St. Amant as General Counsel
June 25, 2024
From
Seismic Therapeutic, Inc.
Via
Business Wire
Seismic Therapeutic Announces Participation at Multiple Upcoming Scientific Conferences in June 2024
June 04, 2024
From
Seismic Therapeutic, Inc.
Via
Business Wire
Seismic Therapeutic to Participate in Upcoming June Investor Conferences
May 29, 2024
From
Seismic Therapeutic, Inc.
Via
Business Wire
Seismic Therapeutic Presents Preclinical Data on S-1117, its Novel Pan-IgG Protease Addressing Multiple Pathogenic Mechanisms in Autoimmune Disease, at American Academy of Neurology (AAN) 2024
April 12, 2024
From
Seismic Therapeutic, Inc.
Via
Business Wire
Seismic Therapeutic Announces Participation at Multiple Upcoming Scientific Conferences in April and May 2024
April 09, 2024
From
Seismic Therapeutic, Inc.
Via
Business Wire
Seismic Therapeutic to Present Preclinical Data for Novel Immunoglobulin Sculpting Enzyme at AAN Annual Meeting
March 08, 2024
From
Seismic Therapeutic, Inc.
Via
Business Wire
Seismic Therapeutic Closes $121 Million Series B Financing to Advance Immunology Pipeline Optimized by its Machine Learning Platform
December 04, 2023
From
Seismic Therapeutic, Inc.
Via
Business Wire
Seismic Therapeutic Announces Presentation of Preclinical Data for Advancing Novel Biologics Drug Programs at the 23rd Annual Meeting of the Federation of Clinical Immunology Societies
June 14, 2023
From
Seismic Therapeutic, Inc.
Via
Business Wire
Seismic Therapeutic Announces Presentation of Preclinical Data Demonstrating Advances in Novel Biologics Discovery at the PEGS Boston Summit
May 11, 2023
From
Seismic Therapeutic, Inc.
Via
Business Wire
Seismic Therapeutic Announces Presentation of Preclinical Data for Immunoglobin Sculpting Enzyme and Dual-Cell Bidirectional Antibody Programs at IMMUNOLOGY 2023
May 09, 2023
From
Seismic Therapeutic, Inc.
Via
Business Wire
Seismic Therapeutic Appoints Melanie Manning as Chief People Officer
March 27, 2023
From
Seismic Therapeutic, Inc.
Via
Business Wire
Seismic Therapeutic Appoints Maude Tessier, PhD, as Chief Business Officer
May 03, 2022
From
Seismic Therapeutic, Inc.
Via
Business Wire
Seismic Therapeutic Launches with $101 Million Series A Financing to Usher in a New Era of Immunology Drug Development Integrating Machine Learning
February 09, 2022
From
Seismic Therapeutic, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.